BCL2L11 and Burkitt lymphoma: Since during latency III, EBNA2 constitutively activates Myc, this repression of Bim expression is probably critical for the immortalisation of B cells by EBV, persistence in vivo and perhaps the development of the endemic EBV-positive form of BL [4],[12] – it is therefore central to EBV biology.